These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 21398087

  • 1. A strategy for conversion from subcutaneous to oral ketamine in cancer pain patients: effect of a 1:1 ratio.
    Benítez-Rosario MA, Salinas-Martín A, González-Guillermo T, Feria M.
    J Pain Symptom Manage; 2011 Jun; 41(6):1098-105. PubMed ID: 21398087
    [Abstract] [Full Text] [Related]

  • 2. Interindividual differences in the analgesic response to ketamine in chronic orofacial pain.
    Rabben T, Øye I.
    Eur J Pain; 2001 Jun; 5(3):233-40. PubMed ID: 11558979
    [Abstract] [Full Text] [Related]

  • 3. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
    Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE.
    Pain Med; 2004 Sep; 5(3):263-75. PubMed ID: 15367304
    [Abstract] [Full Text] [Related]

  • 4. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA.
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [Abstract] [Full Text] [Related]

  • 5. The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain.
    Lasheen W, Walsh D, Mahmoud F, Sarhill N, Rivera N, Davis M, Lagman R, Legrand S.
    Palliat Med; 2010 Jan; 24(1):9-16. PubMed ID: 19910396
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
    Enting RH, Oldenmenger WH, van der Rijt CC, Wilms EB, Elfrink EJ, Elswijk I, Sillevis Smitt PA.
    Cancer; 2002 Jun 01; 94(11):3049-56. PubMed ID: 12115396
    [Abstract] [Full Text] [Related]

  • 8. Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain.
    Mercadante S, Arcuri E, Ferrera P, Villari P, Mangione S.
    J Pain Symptom Manage; 2005 Nov 01; 30(5):485-91. PubMed ID: 16310622
    [Abstract] [Full Text] [Related]

  • 9. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
    Mystakidou K, Befon S, Kouskouni E, Gerolymatos K, Georgaki S, Tsilika E, Vlahos L.
    Anticancer Res; 2001 Nov 01; 21(3C):2225-30. PubMed ID: 11501851
    [Abstract] [Full Text] [Related]

  • 10. The early and delayed analgesic effects of ketamine after total hip arthroplasty: a prospective, randomized, controlled, double-blind study.
    Remérand F, Le Tendre C, Baud A, Couvret C, Pourrat X, Favard L, Laffon M, Fusciardi J.
    Anesth Analg; 2009 Dec 01; 109(6):1963-71. PubMed ID: 19923527
    [Abstract] [Full Text] [Related]

  • 11. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C, Vara F.
    J Pain Palliat Care Pharmacother; 2005 Dec 01; 19(2):7-12. PubMed ID: 16061456
    [Abstract] [Full Text] [Related]

  • 12. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, Villari P, Ficorella C, Gebbia V, Riina S, Casuccio A, Mangione S.
    Eur J Pain; 2008 Nov 01; 12(8):1040-6. PubMed ID: 18353696
    [Abstract] [Full Text] [Related]

  • 13. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
    Ridgway D, Sopata M, Burneckis A, Jespersen L, Andersen C.
    J Pain Symptom Manage; 2010 Apr 01; 39(4):712-20. PubMed ID: 20413058
    [Abstract] [Full Text] [Related]

  • 14. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
    Mercadante S, Villari P, Ferrera P, Porzio G, Aielli F, Verna L, Casuccio A.
    J Pain Symptom Manage; 2006 Aug 01; 32(2):175-9. PubMed ID: 16877185
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pain management of opioid-treated cancer patients in hospital settings in Denmark.
    Lundorff L, Peuckmann V, Sjøgren P.
    Acta Anaesthesiol Scand; 2008 Jan 01; 52(1):137-42. PubMed ID: 18005379
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study.
    Carr DB, Goudas LC, Denman WT, Brookoff D, Staats PS, Brennen L, Green G, Albin R, Hamilton D, Rogers MC, Firestone L, Lavin PT, Mermelstein F.
    Pain; 2004 Mar 01; 108(1-2):17-27. PubMed ID: 15109503
    [Abstract] [Full Text] [Related]

  • 18. Repeated and escalating preoperative subanesthetic doses of ketamine for postoperative pain control in patients undergoing tumor resection: a randomized, placebo-controlled, double-blind trial.
    Rakhman E, Shmain D, White I, Ekstein MP, Kollender Y, Chazan S, Dadia S, Bickels J, Amar E, Weinbroum AA.
    Clin Ther; 2011 Jul 01; 33(7):863-73. PubMed ID: 21722959
    [Abstract] [Full Text] [Related]

  • 19. Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine.
    Hagelberg NM, Peltoniemi MA, Saari TI, Kurkinen KJ, Laine K, Neuvonen PJ, Olkkola KT.
    Eur J Pain; 2010 Jul 01; 14(6):625-9. PubMed ID: 19897389
    [Abstract] [Full Text] [Related]

  • 20. Low-dose intravenous ketamine and clonidine for poor postoperative opioid responsiveness: a double blind randomized study.
    Salengros JC, Hecquet F, Touihri K, Sekkat J, Barvais L, Engelman E.
    Acta Anaesthesiol Belg; 2011 Jul 01; 62(2):65-72. PubMed ID: 21919372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.